KIF1A Gene SPG30 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The KIF1A Gene SPG30 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations associated with hereditary spastic paraplegia type 30 (SPG30). This advanced testing methodology utilizes next-generation sequencing technology to provide comprehensive analysis of the KIF1A gene, which plays a critical role in neuronal transport and function.
What Does the KIF1A Gene SPG30 Test Measure?
This sophisticated genetic test specifically targets and analyzes the KIF1A gene, which encodes a kinesin motor protein essential for axonal transport in neurons. The test detects:
- Pathogenic variants and mutations in the KIF1A gene
- Single nucleotide polymorphisms associated with SPG30
- Copy number variations affecting gene function
- Novel mutations that may cause hereditary spastic paraplegia
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals experiencing:
- Progressive leg stiffness and muscle spasticity
- Difficulty walking or abnormal gait patterns
- Muscle weakness in the lower extremities
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms beginning in childhood or early adulthood
- Developmental delays with progressive motor impairment
Key Benefits of KIF1A Genetic Testing
- Accurate Diagnosis: Provides definitive identification of SPG30 genetic causes
- Family Planning Guidance: Enables informed reproductive decisions
- Early Intervention: Facilitates timely management strategies
- Personalized Treatment: Guides targeted therapeutic approaches
- Genetic Counseling: Supports comprehensive family risk assessment
Understanding Your Test Results
Your genetic test results will provide clear interpretation of findings:
- Positive Result: Indicates presence of pathogenic KIF1A mutation confirming SPG30 diagnosis
- Negative Result: Suggests absence of detectable mutations in tested regions
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact
- Carrier Status: Determines inheritance patterns for family members
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | KIF1A Gene SPG30 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Pre-Test Requirements
Before undergoing testing, we recommend:
- Comprehensive clinical history documentation
- Genetic counseling session with our specialists
- Development of detailed family pedigree chart
- Discussion of testing implications and potential outcomes
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurologists ensures accessible, high-quality care nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. Our KIF1A Gene SPG30 NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With rapid turnaround times and comprehensive genetic analysis, we empower patients and families with essential diagnostic information.
Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your consultation online. Take the first step toward understanding your genetic health and planning for the future.
